Prologue Journal

AstraZeneca agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of AstraZeneca’s efforts to grow its cell therapies business.

• prologu5
• 12/27/202312/27/2023

Wall Street Journal

AstraZeneca agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of AstraZeneca’s efforts to grow its cell therapies business.

https://www.wsj.com/health/astrazeneca-to-buy-gracell-biotechnologies-for-1-2-billion-32f66fbd?mod%3DSearchresults_pos1%26page%3D1